Open Access

Hepatitis B virus and hepatitis C virus in pregnant Sudanese women

  • Rasha M Elsheikh1,
  • Ahmed A Daak1,
  • Mohamed A Elsheikh1,
  • Mubarak S Karsany2 and
  • Ishag Adam1Email author
Virology Journal20074:104

DOI: 10.1186/1743-422X-4-104

Received: 09 August 2007

Accepted: 24 October 2007

Published: 24 October 2007

Abstract

Background

The epidemiology of viral hepatitis during pregnancy is essential for health planners and programme managers. While much data exist concerning viral hepatitis during pregnancy in many African countries, no proper published data are available in Sudan.

Aim

The study aimed to investigate the sero-prevalance and the possible risk factors for hepatitis B virus (HBV) and hepatitis C virus (HCV) among antenatal care attendants in central Sudan.

Methods

During 3 months from March–June 2006, sera were collected from pregnant women at Umdurman Maternity Hospital in Sudan, and they were tested for markers of hepatitis B virus (HBVsAg) and HCV.

Results

HBVsAg was detected in 41 (5.6%) out 728 women, Anti-HCV was detected in 3 (0.6%) out of 423 women, all of them were not aware of their condition. Age, parity, gestational age, residence, history of blood transfusion, dental manipulations, tattooing and circumcision did not contribute significantly to increased HBVsAg sero-positivity.

Conclusion

Thus 5.6% of pregnant women were positive for HBVsAg irrespective of their age, parity and socio-demographic characteristics. There was low prevalence of Anti-HCV.

Introduction

Hepatitis B virus (HBV) infection affects over 350 million people worldwide and over one million die annually of HBV-related chronic liver disease. In endemic areas, most individuals are infected by vertical transmission, or in the early childhood [1]. Hepatitis C virus (HCV) infection is a major worldwide public health problem. The World Health Organization (WHO) estimates that 3% of the world's populations are chronically infected with HCV, most of these cases occur in Africa, which is reported to have the highest HCV prevalence rate [2, 3]. Although, direct percutaneous inoculation is the most efficient mode of transmission of HCV, several studies have demonstrated that sexual, household, occupational, and vertical transmission of HCV may also be of importance [4].

Viral hepatitis during pregnancy is associated with high risk of maternal complications, has a high rate of vertical transmission causing fetal and neonatal hepatitis and it has been reported as a leading cause of maternal mortality in Sudan [58]. The basic epidemiological data for these viruses might be of great importance to the programme mangers and health planners, so as to initiate the relevant vaccine and screening packages in the antenatal care clinics. While, much data exist about the epidemiology of viral hepatitis during pregnancy in other African countries [913], no proper published data are available in Sudan, which is the largest country in Africa. Thus, the current study aimed to investigate the prevalence and the possible risk factors for HBV and HCV among antenatal attendant in central Sudan.

Methods

This was across-section study conducted at Umdurman maternity hospital, Sudan during the period of March–June 2006. After an informed consent all pregnant women attended the first antenatal care visit were approached to participate in the study. A fixed questionnaire was applied to gather relevant socio-demographic characteristics of these women (age, education, gestational age, parity, residence, occupation). Then the possible risk factors (history of surgery or blood transfusion, tattooing, circumcision etc) for HBV were inquired for. After immediate centrifugation, the sera were tested for HBVsAg anti-HCV using ELISA.

Ethics

The study was approved by the Ethics committee of the Faculty of Medicine, Khartoum University and an informed consent was taken from the women.

Statistics

The data were entered in computer and double checked before analysis by SPSS for windows. The means, percentages were calculated and compared between the sero-positive and sero-negative (HBVsAg) using student t-test and chi-square test respectively. Multiple regression was used, sero-positive for HBVsAg as dependent variable and the age, parity, education and the other possible risk factors as independent variables. P > 0.05 was considered significant.

Results

General characteristics of the women

During the study period 728 women were enrolled at 32.1 weeks of gestational age. Their mean (SD) age was 27. 3 (6.2) years. The mean (SD) of the parity was 2.2(1.6), 128 (17.5%) of them were primigravidae. More than one third, 289(40%) of these women had less than secondary level education. 141(19.3%), 63 (8.8%) women gave history of jaundice and blood transfusion, respectively. 69(9%) and 21(3%) had traditional scares and tattooing, respectively. One third of these women (231) had history of dental maneuvers.

HBsAg was detected in 41 (5.6%) out of 728 women, all of them were not aware of their condition. The mean (SD) of the age, parity and gestational age were not significantly different between the sero-positive and sero-negative women (data not shown).

Table 1, showing the results of the univarite and multivariate analysis. None of the expected risk factors (parity, age, history of blood transfusion, dental manipulations, tattooing and circumcision) had been found to be associated with HBVsAg sero-positivity. Due to kids constrains, anit-HCV was tested in the first 423 women. Three (0.6%) out of these were found to be positive.
Table 1

Showing the univarite and multivarite analysis for the possible risk factors for HBV sAg among pregnant women.

Variables

Univarite analysis

Multivarite analysis

 

O R

95% CI

P

O R

95% CI

P

Primigravidae

1.3

0.5–3.1

0.5

1.0

0.4–2.9

0.8

Age ≤27 years

0.9

0.48–1.7

0.7

0.89

0.3–1.9

0.7

Education < secondary school

0.5

0.3–1.0

0.07

0.6

0.2–1.5

0.3

Blood transfusion

1.8

0.75–4.6

0.1

1.9

0.7–5.6

0.19

Surgical operation

1.0

0.3–2.6

0.9

1.5

0.49–4.5

0.4

Circumcision

0.55

0.23–1.2

0.1

0.66

0.22–1.9

0.4

Home delivery

0.9

0.44–1.9

0.8

0.67

0.26–1.7

0.4

Dental manipulation

0.3

0.2–1.2

0.3

0.3

0.12–1.2

0.2

History of jaundice

1.7

0.8–3.5

0.1

1.7

0.7–4.2

0.22

Discussion

Perhaps, this is the first published study documenting sero-prevalence of HBV and HCV among pregnant Sudanese women. Around 5% and less than one percent of these women had been found to be positive for HBVsAg and HCV respectively. Interestingly, this prevalence is much lower in comparison with the prevalence in other African countries [9, 1114]. However, comparison between our study and the others' should be taken cautiously. Firstly different methods had been applied, in our study we aimed to detect antibodies using ELSIA, while some of these studies, DNA of these viruses had been detected rather than antibodies. Secondly the differences in socio-demographic background of these women have to be remembered. Thirdly, the difference in prevalence and interactions of HBV and HCV and HIV might explain the results. Yet, we have recently, documented HIV prevalence in 1% of Sudanese pregnant women of central Sudan [15]. Furthermore, co-infection of HIV and HBV/HCV seems to demonstrate a correlation between these two infections, which could influence the evolution of these diseases [11, 12]. Parallel and overlapping HIV and blood borne hepatitis epidemics in Africa and Influence of maternal (HIV) co-infection on vertical transmission of HCV have been reported before [16, 17]. Thus, the geographical influence of high endemicity in neighboring sub-Saharan countries might change the current situation in the future. Furthermore, even inside Sudan higher prevalence of HBV and HCV had been reported among non-pregnant population of the southern and central Sudan [18, 19].

Unlike the previous reports [14, 20], none of the expected risk factors (age, parity and the other socio-demographic characteristics) for sero-positivity for HBVsAg had been identified in the current study. The explanations for such need to be explore in the future. Other studies are urgently needed to investigate HCV and HIV co-infections and their vertical transmission. Other viruses like hepatitis E should be investigated among the whole population as well as in pregnant Sudanese women.

Conclusion

Thus, 5.6% of pregnant women were positive for HBVsAg irrespective to their age, parity and socio-demographic characteristics. There was a low prevalence of Anti-HCV.

Declarations

Authors’ Affiliations

(1)
Department of Obstetrics & Gynecology, Faculty of Medicine, University of Khartoum
(2)
Department of Pathology, Faculty of Medicine, Juba University

References

  1. Wright TL: Introduction to chronic hepatitis B infection. Am J Gastroenterol 2006,101(Suppl 1):S1-6. 10.1111/j.1572-0241.2006.00469.xPubMedView ArticleGoogle Scholar
  2. WHO: Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999, 6: 35-47. 10.1046/j.1365-2893.1999.6120139.xView ArticleGoogle Scholar
  3. Madhava V, Burgess C, Drucker E: Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2002, 2: 293-302. 10.1016/S1473-3099(02)00264-5PubMedView ArticleGoogle Scholar
  4. Memon M: Hepatitis C: an epidemiological review. J Viral Hepat 2002, 9: 84-100. 10.1046/j.1365-2893.2002.00329.xPubMedView ArticleGoogle Scholar
  5. Elinav E, Ben-Dov IZ, Shapira Y, Daudi N, Adler R, Shouval D, Ackerman Z: Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology 2006,130(4):1129-1134. 10.1053/j.gastro.2006.01.007PubMedView ArticleGoogle Scholar
  6. Ornoy A, Tenenbaum A: Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol 2006, 21: 446-457. 10.1016/j.reprotox.2005.12.007PubMedView ArticleGoogle Scholar
  7. Tse KY, Ho LF, Lao T: The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol 2005, 43: 771-775. 10.1016/j.jhep.2005.05.023PubMedView ArticleGoogle Scholar
  8. Dafallah SE, EL-Agib FH, Bushra GO: Maternal mortality in a teaching hospital in Sudan. Saudi Med J 2003, 24: 369-373.PubMedGoogle Scholar
  9. Laurent C, Henzel D, Mulanga-Kabeya C, Maertens G, Larouze B, Delaporte E: Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo. Int J Epidemiol 2001, 30: 872-877. 10.1093/ije/30.4.872PubMedView ArticleGoogle Scholar
  10. Nacro B, Dao B, Dahourou H, Hien F, Charpentier-Gautier L, Meda N, Van de Perre P, Cartoux M, Mandelbrot L, Dabis F: HBs antigen carrier state in pregnant women in Bobo Dioulasso (Burkina Faso)]. Dakar Med 2000, 45: 188-190.PubMedGoogle Scholar
  11. Simpore J, Ilboudo D, Samandoulougou A, Guardo P, Castronovo P, Musumeci S: HCV and HIV co-infection in pregnant women attending St. Camille Medical Centre in Ouagadougou (Burkina Faso). J Med Virol 2005, 75: 209-212. 10.1002/jmv.20258PubMedView ArticleGoogle Scholar
  12. Simpore J, Savadogo A, Ilboudo D, Nadambega MC, Esposito M, Yara J, Pignatelli S, Pietra V, Musumeci S: Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso. J Med Virol 2006, 78: 730-733. 10.1002/jmv.20615PubMedView ArticleGoogle Scholar
  13. Wurie IM, Wurie AT, Gevao SM: Sero-prevalence of hepatitis B virus among middle to high socio-economic antenatal population in Sierra Leone. West Afr J Med 2005, 24: 18-20.PubMedGoogle Scholar
  14. Ahmed SD, Cuevas LE, Brabin BJ, Kazembe P, Broadhead R, Verhoeff FH, Hart CA: Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women. J Infect 1998, 37: 248-251. 10.1016/S0163-4453(98)91983-1PubMedView ArticleGoogle Scholar
  15. Gassmelseed DE, Nasr AM, Homeida SM, Elsheikh MA, Adam I: Prevalence of HIV infection among pregnant women of the central Sudan. J Med Virol 2006, 78: 1269-1270. 10.1002/jmv.20694PubMedView ArticleGoogle Scholar
  16. Pappalardo BL: Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus (HCV): a meta-analysis. Int J Epidemiol 2003,32(5):727-734. 10.1093/ije/dyg107PubMedView ArticleGoogle Scholar
  17. Gisselquist D, Perrin L, Minkin SF: Parallel and overlapping HIV and bloodborne hepatitis epidemics in Africa. Int J STD AIDS 2004, 15: 145-152. 10.1258/095646204322916560PubMedView ArticleGoogle Scholar
  18. McCarthy MC, el-Tigani A, Khalid IO, Hyams KC: Hepatitis B and C in Juba, southern Sudan: results of a serosurvey. Trans R Soc Trop Med Hyg 1994, 88: 534-536. 10.1016/0035-9203(94)90150-3PubMedView ArticleGoogle Scholar
  19. Mudawi HM, Smith HM, Rahoud SA, Fletcher IA, Babikir AM, Saeed OK, Fedail SS: Epidemiology of HCV infection in Gezira state of central Sudan. J Med Virol 2007, 79: 383-385. 10.1002/jmv.20780PubMedView ArticleGoogle Scholar
  20. Wurie IM, Wurie AT, Gevao SM: Sero-prevalence of hepatitis B virus among middle to high socio-economic antenatal population in Sierra Leone. West Afr J Med 2005, 24: 18-20.PubMedGoogle Scholar

Copyright

© Elsheikh et al; licensee BioMed Central Ltd. 2007

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement